Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Merz global drug safety in germany has received an overall number of 70 case reports (from an estimated total number of 24000 syringes sold) in europe where the device is marketed. short term transient adverse reactions include redness bruising pain and swelling. included in these reports are 26 patients presenting with nodules and 10 patients with indurations mostly in the infra-orbital area.